The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
High-risk HPV type-specific clearance rates in cervical screening
Open accessAbstract
We assessed clearance rates of 14 high-risk human papillomavirus (hrHPV) types in hrHPV-positive women with normal cytology and borderline/mild dyskaryosis (BMD) in a population-based cervical screening cohort of 44,102 women. The 6-month hrHPV type-specific clearance rates, that is, clearance of the same type as detected at baseline, in women with normal and BMD smears were 43% (95% confidence interval (CI) 39-47) and 29% (95% CI 24-34), respectively. Corresponding 18-month clearance rates were markedly higher, namely 65% (95% CI 60-69) and 41% (95% CI 36-47), respectively. The lowest clearance rates in women with normal cytology were observed for HPV16, HPV18, HPV31, and HPV33. Significantly reduced 18-month clearance rates at a significance level of 1% were observed for HPV16 (49%, 95% CI 41-59) and HPV31 (50%, 95% CI 39-63) in women with normal cytology, and for HPV16 (19%, 95% CI 12-29) in women with BMD. Among women who did not clear hrHPV, women with HPV16 persistence displayed an increased detection rate of >or=CIN3 (normal P<0.0001; BMD, P=0.005). The type-specific differences in clearance rates indicate the potential value of hrHPV genotyping in screening programs. Our data support close surveillance (i.e. referral directly, or within 6 months) of women with HPV16 and are inconclusive for surveillance of women with HPV18, HPV31, and HPV33. For the other hrHPV-positive women, it seems advisable to adopt a conservative management with a long waiting period, as hrHPV clearance is markedly higher after 18 months than after 6 months and the risk for >or=CIN3 is low.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Natural History of Cervicovaginal Papillomavirus Infection in Young Women
Ho, G. Y. F., Bierman, R., Beardsley, L., Chang, C. J., & Burk, R. D. (1998) · New England Journal of Medicine · doi:10.1056/nejm199802123380703 · Cited by 2,329
Management of women who test positive for high-risk types of human papillomavirus: the HART study
Cuzick, J., Szarewski, A., Cubie, H., Hulman, G., Kitchener, H., Luesley, D., McGoogan, E., Menon, U., Terry, G., Edwards, R., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14955-0 · Cited by 510
Cited by
Human papillomavirus and cervical cancer
Schiffman, M., Castle, P. E., Jeronimo, J., Rodriguez, A. C., & Wacholder, S. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61416-0 · Cited by 2,985
Risk factors for and prevention of human papillomaviruses (HPV), genital warts and cervical cancer
Chelimo, C., Wouldes, T. A., Cameron, L. D., & Elwood, J. M. (2013) · Journal of Infection · doi:10.1016/j.jinf.2012.10.024 · Cited by 303
Cuschieri, K., & Wentzensen, N. (2008) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-08-0306 · Cited by 273
Heydari, N., Oskouee, M. A., Vaezi, T., Shoja, Z., Esmaeili, H. A., Hamkar, R., Shahmahmoodi, S., & Jalilvand, S. (2018) · Journal of Medical Virology · doi:10.1002/jmv.24908 · Cited by 20
Metadata
- Authors
- on behalf of the POBASCAM Study Group, Bulkmans, N. W. J., Berkhof, J., Bulk, S., Bleeker, M. C. G., van Kemenade, F. J., Rozendaal, L., Snijders, P. J. F., & Meijer, C. J. L. M.
- Venue
- British Journal of Cancer
- Published
- 2007-03-06
- Volume
- 96
- Issue
- 9
- Pages
- 1419-1424
- ISSN
- 0007-0920 (ISSN-L)
- 1532-1827
- OpenAlex
- W2012813126
- Cited by
- 183
- References
- 2
- FWCI
- 7.12
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: High-risk HPV type-specific clearance rates in cervical screening. https://app.cochat.ai/papers/10.1038/sj.bjc.6603653
- The paper
- on behalf of the POBASCAM Study Group, Bulkmans, N. W. J., Berkhof, J., Bulk, S., Bleeker, M. C. G., van Kemenade, F. J., Rozendaal, L., Snijders, P. J. F., & Meijer, C. J. L. M. (2007). High-risk HPV type-specific clearance rates in cervical screening. British Journal of Cancer. https://doi.org/10.1038/sj.bjc.6603653
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.